Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Rallybio Corporation (RLYB) had Normalized Pre-Tax Income of $-72.52M for the most recently reported fiscal year, ending 2023-12-31.
Income Statement Financials | |
-- |
|
$-74.56M |
|
-- |
|
-- |
|
$78.93M |
|
$-78.93M |
|
$6.41M |
|
$-72.52M |
|
Normalized Pre-Tax Income |
$-72.52M |
$-72.52M |
|
$-74.56M |
|
$-74.56M |
|
$-72.52M |
|
$-78.93M |
|
$-81.87M |
|
40.45M |
|
40.45M |
|
$-1.84 |
|
$-1.84 |
|
Balance Sheet Financials | |
$114.79M |
|
$0.25M |
|
$0.83M |
|
$115.62M |
|
$9.26M |
|
-- |
|
$0.17M |
|
$9.44M |
|
$106.18M |
|
$106.18M |
|
$106.18M |
|
37.83M |
|
Cash Flow Statement Financials | |
$-60.27M |
|
$27.66M |
|
$0.14M |
|
$56.96M |
|
$24.49M |
|
$-32.46M |
|
$10.92M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
12.39 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-60.28M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-70.22% |
|
-70.22% |
|
-64.49% |
|
-70.22% |
|
$2.81 |
|
$-1.49 |
|
$-1.49 |